17. November 2009 04:55
Cancer researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have gained new insights into how cells react to DNA damage. Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit have shown that the protein PARP-1, which detects DNA damage within seconds, activates the transcription factor NF-kappaB, a well-known regulator of gene expression.
[More]
16. November 2009 10:19
4SC AG, a drug discovery and development company, today announced the successful completion of a capital increase, after the Management Board, with the approval of the Supervisory Board, passed a resolution to authorise an increase of share capital on 23 October, 2009.
[More]
12. November 2009 07:57
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the third quarter ended September 30, 2009.
[More]
404e795a-2a65-4cf8-a836-c001cbc85a35|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Antibody, Biotechnology, Cancer, Cell, Chemotherapy, Folic Acid, Hodgkin's Lymphoma, Hospital, Hypoxia, Lymphoma, Methotrexate, Monoclonal Antibody, Non-Hodgkin's Lymphoma, Oncology, Osteosarcoma, Rituximab, Yttrium, Zevalin
11. November 2009 01:43
NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the only agent currently approved by the FDA to treat patients with relapsed or refractory peripheral T-cell lymphoma. Investigators from NCCN Member Institutions are eligible to apply for the research funding.
[More]
d8f31f22-e31a-44bf-a6b2-5b853fc7846f|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Cancer, Cell, Chemotherapy, Colorectal Cancer, Head and Neck Cancer, Hodgkin's Lymphoma, Hospital, Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma, Oncology, Ovarian Cancer, Prostate Cancer
6. November 2009 02:05
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
[More]
c92d93a2-ac76-41ce-8871-cbafff4a6e35|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Apoptosis, Arsenic, Biotechnology, Cancer, Cell, Chemotherapy, Chronic Lymphocytic Leukemia, Diarrhea, Fentanyl, Hodgkin's Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Nausea, Nervous System, Neutropenia, Non-Hodgkin's Lymphoma, Oncology, Pneumonia, Rituximab, Vomiting
5. November 2009 23:56
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.
[More]
5. November 2009 02:57
Cell Therapeutics, Inc. today reported recent achievements and financial results for the third quarter and nine months ended September 30, 2009, which included a 45% decrease in the net loss attributable to common shareholders for the nine month period in 2009 compared to the same period in 2008.
[More]
a9ff6416-bf6f-4525-aaf3-8c5acc09ae6d|0|.0
Posted in: Business / Finance
Tags: Biotechnology, Cancer, Cell, Hodgkin's Lymphoma, Investment, Lung Cancer, Lymphoma, New Drug Application, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Oncology, Ovarian Cancer, Small Cell Lung Cancer
28. October 2009 01:11
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
[More]
27. October 2009 08:28
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
[More]
1390c2ed-5424-4638-98ae-15d3991e0ba3|0|.0
Posted in: Pharmaceutical News
Tags: Adalimumab, Alzheimer's Disease, Antibody, Arthritis, Avastin, Bevacizumab, Biotechnology, Cancer, Cetuximab, Crohn's Disease, Eculizumab, Evolution, Genetics, Hodgkin's Lymphoma, Infliximab, Lymphoma, Macular Degeneration, Monoclonal Antibody, Multiple Sclerosis, Non-Hodgkin's Lymphoma, Psoriasis, Ranibizumab, Raptiva, Rheumatoid Arthritis, Rituximab, Transplant, Vectibix, Zevalin
22. October 2009 05:22
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
[More]
74b248a8-f0d4-4193-b507-b88acce24c57|1|5.0
Posted in: Drug Trial News | Medical Condition News
Tags: Anemia, Anthracycline, Breast Cancer, Cancer, Catheter, Cell, Chemotherapy, Congestive Heart Failure, Cough, Cyclophosphamide, Doxorubicin, Heart Failure, Hodgkin's Lymphoma, Hospital, Leukemia, Lymphoma, Neutropenia, Non-Hodgkin's Lymphoma, Oncology, Prescription Drug, Rituximab, Thrombocytopenia, Vincristine
19. October 2009 06:28
NCCN has added pralatrexate (Folotyn(TM), Allos Therapeutics, Inc.) to the NCCN Guidelines for Non-Hodgkin's Lymphomas as one of the options for second-line therapy for relapsed or refractory peripheral T-cell lymphoma.
[More]
19. October 2009 02:05
Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.
[More]
dfcc2ec2-5f02-4e54-bfdd-8356db2d6f5c|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Allergy, Arthritis, Cell, Cyclophosphamide, Fertility, Hodgkin's Lymphoma, Hospital, Infertility, Lymphoma, Neurology, Non-Hodgkin's Lymphoma, Nursing, Orthopedic, Rheumatoid Arthritis, Rheumatology, Vasculitis, Wegener's Granulomatosis
15. October 2009 00:40
Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K. Shinseki decided to establish a service-connection for Vietnam Veterans with three specific illnesses based on the latest evidence of an association with the herbicides referred to as Agent Orange.
[More]
e8917da7-23cd-4fcb-99c8-f44c26a2ce46|0|.0
Posted in: Healthcare News
Tags: Cancer, Cell, Chronic Lymphocytic Leukemia, Diabetes, Diabetes Mellitus, Hairy Cell Leukemia, Hodgkin's Disease, Hodgkin's Lymphoma, Kaposi's Sarcoma, Leukemia, Lymphoma, Mesothelioma, Multiple Myeloma, Neuropathy, Non-Hodgkin's Lymphoma, Osteosarcoma, Parkinson's Disease, Peripheral Neuropathy, Porphyria, Prostate Cancer, Soft Tissue Sarcoma, Veterans Affairs
7. October 2009 06:46
Panel Intelligence, LLC, is pleased to announce expanded capabilities for patient focused market research. For 10 years, Panel Intelligence has provided actionable market intelligence in the form of primary research from clinicians and other healthcare professionals.
[More]
7. October 2009 02:30
Cryo-Cell International, a global leader in stem cell innovation, is proud to be making progress in the fight against breast cancer through research and development using stem cells from menstrual blood.
[More]
ef9f21a1-2e6d-415e-a534-eb7a8a42dcad|0|.0
Posted in: Medical Science News | Women's Health News
Tags: Alzheimer's Disease, Breast Cancer, Cancer, Cell, Diabetes, Hodgkin's Disease, Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin's Lymphoma, Parkinson's Disease, Sickle Cell Disease, Spinal Cord Injury, Stem Cell, Stroke
Subscribe